XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2

Fair Value Measurement (Tables)

6 Months Ended

Jun. 30, 2023

Summary of Financial Items Carried at Fair Value

Financial items carried at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 are classified in the tables below in one of the three categories of fair value levels:

		June 30, 2023
		Level 1				Level 2				Level 3				Total
		(U.S. $ in millions)
Cash and cash equivalents:
Money markets		$	1,080			$	—			$	—			$	1,080
Cash, deposits and other			1,589				—				—				1,589
Investment in securities:
Equity securities			8				—				—				8
Other			4				—				1				5
Restricted cash			1				—				—				1
Derivatives:
Asset derivatives:
Options and forward contracts			—				37				—				37
Cross currency interest rate swaps			—				9								9
Liability derivatives:
Options and forward contracts			—				(47	)			—				(47	)
Bifurcated embedded derivatives			—				—					§			—
Contingent consideration*			—				—				(143	)			(143	)
Total		$	2,682			$	(1	)		$	(142	)		$	2,539

		December 31, 2022
		Level 1				Level 2				Level 3				Total
		(U.S. $ in millions)
Cash and cash equivalents:
Money markets		$	1,222			$	—			$	—			$	1,222
Cash, deposits and other			1,579				—				—				1,579
Investment in securities:
Equity securities			9				—				—				9
Other			5				—				1				6
Restricted cash			33				—				—				33
Derivatives:
Asset derivatives—options and forward contracts			—				29				—				29
Liability derivatives:
Options and forward contracts			—				(101	)			—				(101	)
Bifurcated embedded derivatives			—				—					§			—
Contingent consideration*		$	—				—				(153	)			(153	)
Total			2,848			$	(73	)		$	(152	)		$	2,624

§ Represents an amount less than $0.5 million.

* Contingent consideration represents liabilities recorded at fair value in connection with acquisitions.

Summary of Fair Value of Financial Liabilities Measured Using Level 3 Inputs

The following table summarizes the activity for the financial assets and liabilities where fair value measurements are estimated utilizing Level 3 inputs:

		Six months ended June 30, 2023				Six months ended June 30, 2022
		(U.S. $ in millions)
Fair value at the beginning of the period		$	(152	)			(175	)
Bifurcated embedded derivatives				§				§
Adjustments to provisions for contingent consideration:
Actavis Generics transaction			(64	)			(92	)
Eagle transaction			(24	)			(2	)
Novetide transaction			(1	)			—
Settlement of contingent consideration:
Actavis Generics transaction			57				30
Eagle transaction			40				46
Novetide transaction			2				—
Additional contingent consideration resulting from Novetide acquisition*			—				(11	)
Fair value at the end of the period		$	(142	)		$	(204	)

§ Represents an amount less than $0.5 million.

* In January 2022, Teva acquired 100% ownership of Novetide Ltd. (“Novetide”), which was previously accounted for as “investment in associated companies.” This transaction was accounted for as a business combination. Total consideration for the transaction included cash and certain contingent royalty payments through 2034. As part of the transaction, Teva recognized a gain under “Share in (profits) losses of associated companies, net,” reflecting the difference between the book value of its investment in Novetide and its fair value as of the date Teva completed its acquisition.

Summary of Financial Instrument Measured on a Basis Other Than Fair Value

Financial instruments measured on a basis other than fair value mostly consist of senior notes and convertible senior debentures (see note 7) and are presented in the table below in terms of fair value (level 1 inputs):

		Estimated fair value*
		June 30, 2023				December 31, 2022
		(U.S. $ in millions)
Senior notes and sustainability-linked senior notes included under senior notes and loans		$	16,895			$	16,694
Senior notes and convertible senior debentures included under short-term debt			1,971				2,075
Total		$	18,866			$	18,769

* The fair value was estimated based on quoted market prices.

X

- Definition

Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-SubTopic 10
-Topic 820
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-3

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration